SciELO - Scientific Electronic Library Online

 
vol.28 issue4Treatment by ultrasound-guided neurolysis with 6 % aqueous phenol of the pain component for post-amputation neuromas: report of a clinical case author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la Sociedad Española del Dolor

Print version ISSN 1134-8046

Abstract

BELLA ROMERA, S et al. Brachial plexus schwannoma and botulinum toxin: a case report. Rev. Soc. Esp. Dolor [online]. 2021, vol.28, n.4, pp.242-245.  Epub Nov 08, 2021. ISSN 1134-8046.  https://dx.doi.org/10.20986/resed.2021.3924/2021.

Brachial plexus schwannomas are tumors developed from the neural sheaths of rare presentation, but benign evolution. They can cause symptoms, generally of the neuropathic type, due to local growth with the consequent compressive effect of noble neural structures such as the roots of the brachial plexus.

Botulinum toxin is a neurotoxin synthesized by the bacterium Clostridium Botulinum. Its mechanism of action consists of selectively blocking the cholinergic receptors of the neuromuscular junction, producing a temporary and reversible neuromuscular paralysis, recovering function in approximately three to six months.

We present the case of a patient diagnosed with brachial plexus schwannoma with increasing compre­ssive effect who was treated with botulinum toxin in the scalene muscles.

Keywords : Schwannoma; brachial plexus; botulinum a toxine.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )